WCM
CEMI

Wedge Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Wedge Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-39,500
Closed -$209K – 599
2017
Q1 		$209K Hold
39,500
– – ﹤0.01% 542
2016
Q4 		$269K Hold
39,500
– – ﹤0.01% 525
2016
Q3 		$292K Buy
+39,500
New +$285K ﹤0.01% 518

Other funds holding CEMI

ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NJBEST
New Jersey Better Educational Savings Trust Trenton, New Jersey $62.2M AUM 2.58% 1-Year Est. Return

Wedge Capital Management's CEMI Position: Q2 2017 in Review

Wedge Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2017, closing a stake of 39,500 shares — an estimated $209K sold.

Wedge Capital Management first reported a position in CEMI in Q3 2016 and held it in 3 quarters. The position peaked at $292K in Q3 2016. 24 funds tracked by Wall St. Rank hold CEMI as of Q2 2017.

  • Wedge Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Wedge Capital Management sold 39,500 Chembio diagnostics, Inc. shares in Q2 2017, an estimated $209K.
  • Wedge Capital Management first reported a position in Chembio diagnostics, Inc. in Q3 2016 and held it in 3 quarters.
  • Wedge Capital Management's Chembio diagnostics, Inc. position peaked at $292K in Q3 2016.
  • 24 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2017.

Based on Wedge Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.